A study of GC7 for heart attack patients
Part of Heart & circulation clinical trials.
This trial tests a drug called GC7 to see if it helps people who have had a cardiac arrest. It aims to protect the heart and improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were admitted to the hospital mainly because your heart stopped.
- You were admitted less than 48 hours ago.
- You are 18 years old or older.
- You have a social security number or equivalent health coverage.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special CT scan of the heart can help doctors see blockages in people who survived a cardiac arrest but did not have a typical heart attack. If you qualify, the CT scan might provide important information without needing a standard heart catheterization first.
This trial tests whether care from a specialist team helps people recover better after a cardiac arrest outside the hospital. If you were revived and brought to the emergency department with a pulse, you might be eligible.
This trial tests an investigational device called Neurescue, used alongside standard CPR and life support to treat adults who have had a witnessed cardiac arrest. It is designed for people whose heart cannot be restarted by a shock and who receive CPR very soon after collapse.
This trial tests two treatments for people who are unconscious after their heart stops: a specific head position and a way to control body temperature. The goal is to see if these treatments help improve recovery.
This study tests a different way of doing CPR (cardiopulmonary resuscitation) when someone's heart stops. It aims to see if this adapted approach can improve outcomes for patients.
This trial is studying a new system where trained volunteers respond quickly to help people whose heart stops outside of a hospital in Zug, Switzerland. The goal is to see if this system improves survival and recovery.
Hear when a new Cardiac Arrest (CA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.